| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.7B | $20.7B | $28.2B | $7.6B | $26.3B | $8.6B | $3.3B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.7B | $3.5B | $4.7B | $-4.2B | $3.9B | $1.1B | $0.5B | $-0.1B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $442.2B | $363.3B | $300.6B | $246.0B | $235.1B | $202.8B | $146.9B | $125.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | $13.0B | $7.8B | $9.6B | $7.7B | — | $3.4B |
| Total Liabilities | $406.6B | $337.5B | $279.3B | $243.7B | $213.0B | $182.6B | $132.7B | $117.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $20.5B | $16.4B | $13.8B | $0.9B | $20.1B | $18.7B | $13.4B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.2B | $1.9B | $5.0B | $6.3B | $10.3B | $4.2B | $2.7B | $2.9B |
| Investing Cash Flow | $-63.8B | $-61.9B | $-43.6B | $-34.4B | $-27.9B | $-14.8B | $-10.0B | $-8.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $61.3B | $59.4B | $44.8B | $26.5B | $19.6B | $14.5B | $8.5B | $3.7B |